发明名称 Hemojuvelin fusion proteins and uses thereof
摘要 The present invention provides a hemojuvelin (HJV) fusion protein (e.g., a human HJV.Fc) protein, polynucleotides and vectors encoding such proteins, and methods for making such proteins. Also provided are methods for treating iron-related disorders which include administration of a HJV fusion protein to a patient in need thereof.
申请公布号 US8895002(B2) 申请公布日期 2014.11.25
申请号 US200812595423 申请日期 2008.04.09
申请人 The General Hospital Corporation 发明人 Lin Herbert Y.;Babitt Jodie;Woolf Clifford J.;Samad Tarek A.
分类号 A61K38/18;C07K14/475;C12N15/62;C12N15/63;C07H21/04;C07K14/71 主分类号 A61K38/18
代理机构 Lathrop & Gage LLP 代理人 Lathrop & Gage LLP
主权项 1. A fusion protein comprising: (a) a hemojuvelin (HJV) polypeptide or fragment thereof, wherein said polypeptide or fragment thereof has at least 95% amino acid sequence identity to a portion of the HJV protein of SEQ ID NOs: 2, 3 or 4 and is at least 50 amino acids in length; and (b) a first fusion partner, wherein said first fusion partner is conjugated to said HJV polypeptide or fragment thereof, wherein said first fusion partner is an IgG1 Fc; and (c) a second fusion partner.
地址 Boston MA US